55+ min ago  (589+ words) With income back in favour, this high-yield strategy has delivered a strong result over the past 12 months. It has been an interesting 12 months for the share market. Income-focused shares, particularly banks and miners, have done a lot of the heavy…...

1+ hour, 38+ min ago  (761+ words) These ASX 200 shares are trading at dirt-cheap prices right now. The S&P/ASX 200 Index (ASX: XJO) is down another 0. 5% in Wednesday morning trade, continuing a run of six consecutive days of losses. Concerns about new inflation data and a…...

3+ hour, 33+ min ago  (646+ words) ASX 200 investors favoured their buy buttons after the latest Aussie inflation reading. But why? The S&P/ASX 200 Index (ASX: XJO) was down 0. 4% at 8, 673 points when the clock struck 11: 30am AEST today. In the minutes that followed, Australia's benchmark stock market…...

3+ hour, 53+ min ago  (217+ words) Analysts are very bullish about the outlook for these ASX 200 stocks. The S&P/ASX 200 Index (ASX: XJO) has tumbled again in early morning trade on Wednesday as inflation fears, interest rate hike concerns, and surging oil prices continue to…...

2+ hour, 1+ min ago  (601+ words) Liontown, Ramelius Resources and Woodside shares are making headlines today. But why? Ramelius Resources Ltd (ASX: RMS), Liontown Resources Ltd (ASX: LTR), and Woodside Energy Group Ltd (ASX: WDS) shares are catching heightened investor interest on Wednesday. Two of the…...

2+ hour, 11+ min ago  (542+ words) Tivan shares jump 8% after the release of the scoping study for Molyhil. Tivan Ltd(ASX: TVN) is back on the boards on Wednesday, and the market has responded straight away. After coming out of atrading halt, the critical minerals developer's…...

6+ hour, 38+ min ago  (574+ words) Shares in Domino's Pizza Enterprises Ltd (ASX: DMP) took another hit on Tuesday, tumbling 11% to $15. 85. That extends a rough run for investors. The ASX stock is now down around 25% year to date and roughly 38% over the past 12 months. By comparison,…...

3+ hour, 55+ min ago  (565+ words) Mesoblast hits a key trial milestone" A key clinical milestone has put ASX biotech stock'Mesoblast Ltd'(ASX: MSB) back on the radar on Wednesday. The biotech announced a key milestone before the market opened, though investors are not getting carried…...

4+ hour, 17+ min ago  (581+ words) It goes from bad to worse for this struggling company. G8 Education Ltd (ASX: GEM) shares are having a day to forget on Wednesday. In morning trade, the ASX 300 share is down 31% to a multi-year low of 16. 5 cents. This follows the…...

5+ hour, 28+ min ago  (479+ words) Mesoblast shares are in focus after reaching a major patient recruitment milestone in its pivotal Phase 3 trial for chronic low back pain. The Mesoblast Ltd (ASX: MSB) share price is in focus after the company announced it has reached its…...